Exagen Inc. XGN
Set alert
8.39 USD -0.20 -2.33%
At close · Nov 2
8.39 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
8.21 Day range 8.67
2.59 52-week range 11.50
- YTD
- +37.99%
- 1 year
- -28.11%
- Open
- 8.59
- Prev close
- 8.59
- Mkt cap
- 203.25M
- Vol
- 243.09K
- Avg vol
- 370.74K
- EPS
- -0.81
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.21
- High
- 8.67
- Forward P/E
- -5.96
- Beta
- 1.35
- Short ratio
- 3.12
- Inst. own
- 57.22%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 5, 2024
- 50-d avg
- 3.59
- 200-d avg
- 2.50
- 1y target
- 6.25
MAX chart
Events in this range
- Nov 17, 2022Rating: BTIG · — → Buy
- Mar 22, 2023Rating: BTIG · — → Buy
- May 16, 2023Rating: Cantor Fitzgerald · Overweight → Overweight
- Aug 22, 2023Rating: Cantor Fitzgerald · Overweight → Overweight
- Sep 26, 2023Rating: Cantor Fitzgerald · Overweight → Overweight
- Mar 18, 2024Earnings: -0.31; estimate -0.41; surprise 24.39%
- May 13, 2024Earnings: —; estimate -0.4; surprise —%
- May 13, 2024Earnings: -0.19; estimate -0.4; surprise 52.5%
- May 14, 2024Rating: Cantor Fitzgerald · Overweight → Overweight
- Aug 5, 2024Earnings: -0.16; estimate -0.36; surprise 55.56%
- Aug 5, 2024Earnings: —; estimate -0.36; surprise —%
- Nov 12, 2024Earnings: -0.28; estimate -0.3; surprise 6.67%
Signals (112)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 26, 2026 | 1 week ago |
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| RSI: Overbought | Sep 21, 2026 | 1 month ago |
| RSI: Overbought | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 27, 2026 | 3 months ago |
| SMA: Bullish | Jul 20, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 25, 2026 | 5 months ago |
| SMA: Bullish | May 11, 2026 | 5 months ago |
| SMA: Bearish | May 4, 2026 | 6 months ago |
| SMA: Bullish | Apr 27, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 27, 2026 | 6 months ago |
| RSI: Oversold | Jan 12, 2026 | 9 months ago |
| SMA: Bearish | Nov 17, 2025 | 11 months ago |
| SMA: Bearish | Nov 3, 2025 | 1 year ago |
| MACD: Sell Signal | Nov 3, 2025 | 1 year ago |
| RSI: Overbought | Jul 28, 2025 | 1 year ago |
Newest 20 of 112.
Financial health
Altman Z-Score
-4.42 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
D+1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -6.5×
FY 2015 5y median -4.9× FY 2025
P/S 2.0×
FY 2015 5y median 1.3× FY 2025
P/B 7.5×
FY 2015 5y median 2.2× FY 2025
P/FCF -9.2×
FY 2015 5y median -5.4× FY 2025
EV/EBITDA -9.3×
FY 2015 5y median -5.0× FY 2025
EV/Sales 1.9×
FY 2015 5y median 1.4× FY 2025
FCF Yield -10.9%
FY 2015 5y median -18.5% FY 2025
Profitability
Gross Margin 58.3%
FY 2015 5y median 57.4% FY 2025
Operating Margin -21.1%
FY 2015 5y median -43.5% FY 2025
Net Margin -30.0%
FY 2015 5y median -45.1% FY 2025
ROE -114.3%
FY 2015 5y median -111.6% FY 2025
ROIC -30.0%
FY 2015 5y median -41.4% FY 2025
ROA -34.4%
FY 2015 5y median -34.4% FY 2025
Growth (YoY)
Revenue 19.7%
FY 2015 FY 2025
Operating Income -3.2%
FY 2015 FY 2025
EPS (diluted) -12.0%
FY 2015 FY 2025
Free Cash Flow -3.4%
FY 2015 FY 2025
Financial Health
Current Ratio 3.5×
FY 2015 5y median 4.0× FY 2025
Quick Ratio 3.5×
FY 2015 5y median 4.0× FY 2025
Debt / Equity 1.5×
FY 2015 5y median 1.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2015 5y median 0.6× FY 2025
Interest Coverage -3.3×
FY 2015 5y median -9.2× FY 2025
Dividends
Dividend Yield 0.0%
FY 2015 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2015 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
